Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous ETX2514 Administered in Healthy Subjects
Clinical trial NCT02971423 · COMPLETED
Trial details
- NCT number
- NCT02971423
- Sponsor
- Entasis Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-06-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.